MLICM
IMGN

Metropolitan Life Insurance Company (MetLife)’s Immunogen Inc IMGN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,608
Closed -$403K – 2367
2023
Q4 		$403K Sell
13,608
-371
-3% -$7.39K 0.02% 511
2023
Q3 		$222K Buy
13,979
+795
+6% +$13.2K 0.01% 635
2023
Q2 		$249K Buy
13,184
+2,757
+26% +$32.6K 0.01% 593
2023
Q1 		$40K Sell
10,427
-2,505
-19% -$10.7K ﹤0.01% 1522
2022
Q4 		$64.1K Hold
12,932
– – ﹤0.01% 1322
2022
Q3 		$61.8K Buy
12,932
+2,738
+27% +$14.4K ﹤0.01% 1314
2022
Q2 		$45.9K Sell
10,194
-2,529
-20% -$11K ﹤0.01% 1563
2022
Q1 		$60.6K Sell
12,723
-38,981
-75% -$216K ﹤0.01% 1482
2021
Q4 		$384K Buy
51,704
+1,029
+2% +$6.39K 0.01% 1597
2021
Q3 		$287K Buy
50,675
+7,577
+18% +$43.8K ﹤0.01% 1809
2021
Q2 		$284K Sell
43,098
-5,795
-12% -$40.4K ﹤0.01% 1899
2021
Q1 		$396K Sell
48,893
-2,122
-4% -$17.3K 0.01% 1563
2020
Q4 		$329K Buy
51,015
+8,637
+20% +$50.4K ﹤0.01% 1630
2020
Q3 		$153K Sell
42,378
-12,248
-22% -$49.5K ﹤0.01% 1949
2020
Q2 		$251K Sell
54,626
-57
-0.1% -$242 ﹤0.01% 1654
2020
Q1 		$186K Buy
54,683
+8,332
+18% +$36.4K ﹤0.01% 1628
2019
Q4 		$237K Sell
46,351
-2,348
-5% -$7.97K ﹤0.01% 1796
2019
Q3 		$118K Hold
48,699
– – ﹤0.01% 2212
2019
Q2 		$106K Buy
48,699
+7,328
+18% +$17.3K ﹤0.01% 2279
2019
Q1 		$112K Sell
41,371
-5,646
-12% -$24.5K ﹤0.01% 2257
2018
Q4 		$226K Hold
47,017
– – ﹤0.01% 1732
2018
Q3 		$445K Buy
47,017
+4,824
+11% +$46.4K 0.01% 1454
2018
Q2 		$411K Buy
42,193
+8,543
+25% +$90.1K 0.01% 1452
2018
Q1 		$354K Buy
33,650
+3,552
+12% +$35.1K 0.01% 1495
2017
Q4 		$193K Sell
30,098
-35,580
-54% -$219K ﹤0.01% 1931
2017
Q3 		$502K Sell
65,678
-839
-1% -$5.58K ﹤0.01% 1685
2017
Q2 		$473K Hold
66,517
– – ﹤0.01% 1733
2017
Q1 		$257K Buy
+66,517
New +$194K ﹤0.01% 2103
2016
Q4 		– Sell
-59,929
Closed -$161K – 2651
2016
Q3 		$161K Sell
59,929
-9,021
-13% -$26.2K ﹤0.01% 2463
2016
Q2 		$212K Hold
68,950
– – ﹤0.01% 2285
2016
Q1 		$587K Buy
68,950
+8,848
+15% +$74.9K ﹤0.01% 1492
2015
Q4 		$816K Hold
60,102
– – 0.01% 1294
2015
Q3 		$577K Sell
60,102
-5,237
-8% -$76.6K ﹤0.01% 1541
2015
Q2 		$940K Sell
65,339
-3,950
-6% -$43.4K 0.01% 1331
2015
Q1 		$620K Sell
69,289
-113
-0.2% -$819 ﹤0.01% 1444
2014
Q4 		$423K Hold
69,402
– – ﹤0.01% 1877
2014
Q3 		$735K Hold
69,402
– – 0.01% 1470
2014
Q2 		$822K Hold
69,402
– – 0.01% 1487
2014
Q1 		$1.04M Hold
69,402
– – 0.01% 1323
2013
Q4 		$1.02M Hold
69,402
– – 0.01% 1317
2013
Q3 		$1.18M Hold
69,402
– – 0.01% 1187
2013
Q2 		$1.15M Buy
+69,402
New +$1.12M 0.01% 1153

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s IMGN Position: Q1 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 13,608 shares — an estimated $403K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in IMGN in Q2 2013 and held it in 42 quarters. The position peaked at $1.18M in Q3 2013. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 13,608 Immunogen Inc shares in Q1 2024, an estimated $403K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Immunogen Inc in Q2 2013 and held it in 42 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Immunogen Inc position peaked at $1.18M in Q3 2013.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2024, filed 14 May 2024.